Cover Image

Possibilities of preserving reproductive function in female patients with atypical hyperplasia and endometrial cancer at an early stage

<p> O.F. Serova<sup>1</sup>, Yu.E. Dobrokhotova<sup>2</sup>, E.I. Borovkova<sup>2</sup>, A.V. Charkhifalakyan<sup>3</sup> </p> <p> <sup>1</sup>Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agen...

Full description

Saved in:

Bibliographic Details
Main Authors:	O.F. Serova (Author), Yu.E. Dobrokhotova (Author), E.I. Borovkova (Author), A.V. Charkhifalakyan (Author)
Format:	Book
Published:	LCC «Medicine-Inform», 2023-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Reproductive advance of fertility preservation in patients with early endometrial carcinoma or endometrial atypical hyperplasia
by: Jiao Yu, et al.
Published: (2022)

Outcomes of organ-preserving treatment of atypical hyperplasia and early stage endometrial cancer in reproductive age: A prospective and retrospective study
by: Lyubov T. Gadzhieva, et al.
Published: (2023)

Laparoscopic surgery for atypical endometrial hyperplasia with awareness regarding the possibility of endometrial cancer
by: Misato Kamii, et al.
Published: (2023)

The reproductive function of patients with prior atypical endometrial hyperplasia and endometrial cancer treatment: cohort study
by: Lana G. Dzhanashvili, et al.
Published: (2022)

Pregnancy outcomes after fertility preservation in women with endometrial carcinoma and atypical endometrial hyperplasia: A systematic review and meta-analysis
by: Zerui Xiao, et al.
Published: (2021)

Effectiveness of megestrol for the treatment of patients with atypical endometrial hyperplasia or endometrial endometrioid adenocarcinoma (Stage IA, well differentiated)
by: Setareh Akhavan, et al.
Published: (2021)

Results of surgical treatment of atypical endometrial hyperplasia
by: O. A. Gornykh, et al.
Published: (2014)

Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia
by: Yuan Fan, et al.
Published: (2021)

Restoration of endometrial receptivity and reproductive function in infertile women with excess body weightand complex non-atypical endometrial hyperplasia
by: O. Nosenko, et al.
Published: (2022)

Microsatellite instability as a reliable marker of coexisting endometrial cancer in atypical endometrial hyperplasia
by: А. E. Protasova, et al.
Published: (2024)

Endometrial hyperplasia process in female patients with chronic kidney disease: the choice of treatment tactics
by: Yu.E. Dobrokhotova, et al.
Published: (2023)

Correlation of plasma adipokines with endometrial atypical hyperplasia and type I/II endometrial cancer
by: Xinxin Zhu, et al.
Published: (2023)

Diagnostic accuracy of hysteroscopic scoring system in predicting endometrial malignancy and atypical endometrial hyperplasia
by: Bhukya Harika, et al.
Published: (2021)

Value of endometrial thickness for the detection of endometrial cancer and atypical hyperplasia in asymptomatic postmenopausal women
by: Linna Zhang, et al.
Published: (2022)

Weight-loss interventions and levonorgestrel intrauterine system implantation for early-stage endometrial cancer and atypical endometrial hyperplasia to reduce perioperative risk of severely obese patients
by: Roze Isono-Taniguchi, et al.
Published: (2023)

Comparatively analyzed quality of life in patients with atypical endometrial hyperplasia and endometrial cancer during various rehabilitation activities
by: L. N. Sandzhieva, et al.
Published: (2022)

Prevention of endometrial hyperplasia without atypia in women of reproductive age
by: Mekan R. Orazov, et al.
Published: (2021)

Hypoxic damage and neovascularization of endometrium in endometrial hyperplasia
by: E.A. Kazachkova, et al.
Published: (2019)

Non-atypical endometrial hyperplasia: risk factors for occult endometrial atypia and malignancy in patients managed with hysterectomy
by: Lee Shi Hui, et al.
Published: (2021)

Risk of endometrial cancer in patients with a preoperative diagnosis of atypical endometrial hyperplasia treated with total laparoscopic hysterectomy
by: Katsutoshi Oda, et al.
Published: (2016)

Risk factors for atypical hyperplasia and endometrial cancer in the infertility population: a case-control study
by: Jenna L. Kahn, M.D, et al.
Published: (2021)

Current view of the management of patients with endometrial hyperplasia: A review
by: Aznar S. Khachatryan, et al.
Published: (2024)

Efficacy of the LNG-IUS for treatment of endometrial hyperplasia and early stage endometrial cancer: Can biomarkers predict response?
by: Molly Dore, et al.
Published: (2021)

Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients
by: Yingqiao Ding, et al.
Published: (2022)

Predictors of recurrent course of endometrial hyperplasia without atypia in women of reproductive age
by: Mekan R. Orazov, et al.
Published: (2023)

An integrated approach to the management of patients with endometrial hyperplasia and metabolic syndrome
by: Irina A. Lapina, et al.
Published: (2021)

Atypical hyperplasias of the breast
by: I. V. Vysotskaya, et al.
Published: (2015)

Is it safe to preserve the ovary of premenopausal women with supposed early-stage endometrial cancer?
by: Fa-Kung Lee
Published: (2016)

Analysis of the objective and preventative treatment and efficacy of therapeutic approaches in women with non-atypical endometrial hyperplasia
by: O. L. Gromova
Published: (2020)

Surgical Treatment of Endometrial Cancer and Atypical Hyperplasia: A Trend Shift from Laparotomy to Laparoscopy
by: Erik Qvigstad, et al.
Published: (2011)

Possibilities of rehabilitation in cancer patients to preserve their reproductive function
by: L. V. Adamyan, et al.
Published: (2014)

Caspase-3 mediated Apoptosis AT the endometrial hyperplasia in women of reproductive age
by: V. G. Dubinina, et al.
Published: (2016)

Caspase-3 mediated Apoptosis AT the endometrial hyperplasia in women of reproductive age
by: V. G. Dubinina, et al.
Published: (2016)

MOLECULAR PROFILES OF ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA
by: S. A. Levakov, et al.
Published: (2018)

Fertility preservation problem in oncohematological patients of reproductive age
by: Yu.E. Dobrokhotova, et al.
Published: (2023)

Hyperplasia and endometrial precancer
by: O. A. Gornikh, et al.
Published: (2014)

Characteristics of molecular classification in 52 endometrial cancer and atypical hyperplasia patients receiving fertility-sparing treatment
by: Yiqin Wang, et al.
Published: (2023)

Correlation between steroid receptor expression and response to progestational therapy in patients with atypical endometrial hyperplasia or cancer
by: Fadi Zaiem, et al.
Published: (2024)

Risk factors for recurrence of endometrial hyperplasia in women of late reproductive and premenopausal age
by: С. М. Корниенко
Published: (2017)

USE OF GONADOTROPIN-RELEASING HORMONE AGONISTS IN TREATMENT OF RECURRENT PRE-MENSTRUAL ENDOMETRIAL HYPERPLASIA
by: Yu. E. Dobrokhotova, et al.
Published: (2016)